FOXP3 and cancer: We quantified the frequencies of CD4+CD25+FOXP3+ Tregs in all groups and found a significant reduction in Tregs in the C + I vaccine group compared with PBS in both TDLNs and the spleen (Figure 3C), reversing the immune-suppressive microenvironment in mice injected with cancer cells.